首页> 外文期刊>Drug and alcohol dependence >Abuse liability of oxycodone as a function of pain and drug use history.
【24h】

Abuse liability of oxycodone as a function of pain and drug use history.

机译:羟考酮的滥用责任与疼痛和吸毒史的关系。

获取原文
获取原文并翻译 | 示例
       

摘要

The relationship between pain and prescription opioid abuse is poorly understood. Determining whether a patient is seeking additional opioid medications in order to alleviate pain or to abuse the drugs can be difficult. The present study was designed to evaluate two variables that may influence the abuse liability of opioids: drug use history and the presence or absence of experimentally induced pain. Eighteen healthy participants completed this outpatient study. One group was abusing prescription opioids (N=9) and one group had used prescription opioids medically but did not abuse them (N=9). All participants completed twelve sessions during which the effects of orally delivered oxycodone (0, 15, 30mg/70kg, PO) were examined. One dose was tested per day under double-blind conditions and sessions were separated by at least 48h. During the first "sample" session each week, participants were given Dollars 10 and the dose that was available later that week. During the second "choice" session, participants could self-administer either money or the previously sampled dose. Six sessions involved repeated hand immersions in cold water (4 degrees C) and six sessions involved immersions in warm water (37 degrees C). Most of the positive subjective effects of oxycodone were similar between the groups, but oxycodone self-administration significantly differed between groups. Non-abusers self-administered active doses of oxycodone only when they were in pain while abusers self-administered oxycodone regardless of the pain condition. These data suggest that an assessment of the reinforcing effects of opioids may be a sensitive method for differentiating opioid abusers from non-abusers.
机译:疼痛与处方阿片类药物滥用之间的关系知之甚少。确定患者是否正在寻求其他阿片类药物以减轻疼痛或滥用药物可能很困难。本研究旨在评估可能影响阿片类药物滥用责任的两个变量:药物使用史和实验性疼痛的存在与否。 18名健康参与者完成了该门诊研究。一组滥用处方阿片类药物(N = 9),一组曾在医学上使用处方阿片类药物但未滥用(A = 9)。所有参与者完成了十二节课,在此期间检查了口服羟考酮(0、15、30mg / 70kg,PO)的作用。每天在双盲条件下测试一剂,每次治疗至少间隔48小时。在每周的第一个“样本”会议期间,向参与者提供10美元以及该周晚些时候可用的剂量。在第二个“选择”阶段中,参与者可以自行管理金钱或先前采样的剂量。六节课涉及反复将手浸入冷水(4摄氏度)中,六节课涉及将手浸入温水(37摄氏度)中。两组之间羟考酮的大多数积极主观效果相似,但两组之间羟考酮的自我给药明显不同。非滥用者只有在疼痛时才自行服用活性剂量的羟考酮,而滥用者则不管疼痛状况如何都自行服用羟考酮。这些数据表明,评估阿片类药物的增强作用可能是区分阿片类药物滥用者与非滥用者的敏感方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号